Malaria Consortium supports the delivery of seasonal malaria chemoprevention (SMC) to children 3–59 months during the rainy season in countries where transmission is highly seasonal. This involves four monthly doses of sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) and has been shown to provide effective protection against clinical Plasmodium
falciparum malaria cases. We adapted the lot quality assurance sampling method for end-of-cycle SMC monitoring surveys in Burkina Faso, Chad, Nigeria, Togo and Mozambique to measure quality of delivery across 16 indicators. Surveys took place after cycles 1–3 in 2020 and 2021 to facilitate local assessment of programme performance at the supervision area level using hypothesis tests to determine whether indicator standards had been met. We aimed to promote rapid use of data from monitoring surveys to drive ongoing improvements in SMC delivery within a given SMC round.
This poster was presented at the 70th annual meeting of the American Society of Tropical Medicine and Hygiene.Community delivery | Health system strengthening | Malaria | Seasonal malaria chemoprevention | SDG3
« Back to Publications